NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode Performed at Mayo Clinic
10 mai 2023 09h00 HE
|
NeuroOne Medical Technologies Corp
Evo sEEG electrodes used for brain mapping in epilepsy surgery EDEN PRAIRIE, Minn., May 10, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the...
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05 mai 2023 15h08 HE
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., May 05, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
NeuroOne® to Present at the Sidoti Micro-Cap Virtual Conference on May 10
05 mai 2023 09h00 HE
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., May 05, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
NeuroOne® Announces U.S. Commercial Launch of Evo® sEEG Electrodes
02 mai 2023 09h00 HE
|
NeuroOne Medical Technologies Corp
Evo sEEGs complementary to Zimmer Biomet’s robotic neurosurgery platform; strong market opportunity for paired technologies EDEN PRAIRIE, Minn., May 02, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical...
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
27 avr. 2023 16h00 HE
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., April 27, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...